A Broad-Spectrum Immune Enhancer
Published peer-reviewed research papers have shown that numerous different diseases involving the immune dysregulation such as cancer, neurodegenerative and neurodevelopmental disorders, autoimmune conditions, and viral infections are linked to elevated levels of an immunosuppressive enzyme called nagalase [1]. Serum nagalase levels have been used as a diagnostic indicator for a variety of conditions ranging from cancer to autism.
Nagalase Shuts Down the Immune System
Nagalase reduces natural VDBP-MAF production and stimulates immunosuppression pathways. The enzyme inhibits macrophage activation, which shuts down the body’s natural immune defense systems and facilitates disease progression.
Providing an external source of VDBP-MAF in sufficient amounts to activate macrophages can provide significant clinical benefits for immune-compromised patients [3]. Nagalase cannot deactivate supplemental VDBP-MAF as the enzyme has specificity for VDBP – the precursor protein required for VDBP-MAF synthesis.
Immunax Restores Immune Function
iMAP therapy with Immunax supports healthy immune function and helps to restore natural healing processes in immune-compromised patients. Immunax acts like the commanding officer of your immune system.
The active ingredient VDBP-MAF is a powerful messenger molecule that regulates immune surveillance and attack. It activates dormant macrophages, which in turn mount an integrated immune response and recruit other key immune cells to fight infection and illness. Immunax has therapeutic benefits for a range of different conditions.
